Daily Management Review

American authorities spoke out against electronic cigarettes iQOS


01/26/2018


The tobacco company Philip Morris International has not yet proved that its iQOS heating devices are less harmful than conventional cigarettes. The Food and Drug Administration (FDA) of the United States said it has no evidence that the risk of various diseases is lower when using iQOS. The decision is not final as Philip Morris can still present evidence of a lesser risk of iQOS.



Vaping360 via flickr
Vaping360 via flickr
Experts from the Office for Food and Drug Administration examined iQOS, electronic cigarettes with tobacco heating, manufactured by Philip Morris International, and concluded that the company has no right to assert that their use is less dangerous than smoking cigarettes. The tobacco company appealed to the FDA for permission to write in iQOS advertising that the use of the device is safer than smoking. FDA experts said that they have no evidence that it is less harmful. In their view, when tobacco is heated, fewer harmful substances are actually released than when burned, yet Philip Morris failed to prove that the risk of various diseases when using iQOS is indeed lower than with conventional smoking.

IQOS are electronic cigarettes, in which tobacco is not burned, but is heated. They were developed by Philip Morris, and are now used by about 4 million people worldwide and are sold in 30 countries. The company spent about $ 3 billion on developing these devices. According to Philip Morris, using iQOS is 95% safer than smoking.

Philip Morris has high expectations for iQOS: in July, its CEO, André Calantzopoulos, said that the company will gradually reduce the production of cigarettes and replace them with iQOS tobacco heating systems. According to experts, the current FDA decision is unlikely to be final. The controller may eventually end up recognizing iQOS as less harmful, but will first ask Philip Morris for more information about the device. So, Wells Fargo analyst Bonnie Herzog believes that the FDA is likely to approve the application of Philip Morris, but "the timing of this is difficult to predict."

The shares of Philip Morris fell by 6.8% on Thursday. Later on, they grew, remaining nevertheless by 2.8% lower than the day before.

Recall that Philip Morris has promised to abandon the production of cigarettes in the new year - so far only in the UK. This writes Business Insider. It is reported that the corporation has invested 2.5 billion pounds in the development of alternative products for smokers.

In September 2017, the World Health Organization rejected the Philip Morris anti-smoking initiative and recommended that governments do the same. According to the medical organization, the tobacco lobby only misinforms people about allegedly harmless electronic cigarettes.

source: reuters.com






Science & Technology

Apple takes up to develop Apple Watch for health monitoring

Hyperloop is growing in Europe

Analysts: US gamers prefer mobile games

Google Assistant Winner Of Head-To-Head Test Of Digital Assistants, Beats Siri And Alexa

Animals Can Burn Muscle To Supplement Body Water Needs, Finds A Study

The future of private flights at Farnborough air show

Experts Want To Fix Problem Of AI Hurting People Of Color And The Poor

New Study Claims Astrobiologists Locating Possible Life On Moon In Its Life Time

Wreck Of Russian Ship Rumoured To Have 5,500 Boxes Of Gold Found Near South Korean Island

Gene Editing of Human Embryo Could Find ‘Moral’ Grounds: UK’s Ethics Council

World Politics

World & Politics

Venezuela comes up with a new monetary reform

Paris is losing its icon public bicycle sharing system

Heat wave in Europe creates problems for brewers

Is it legal to print a gun? US is discussing 3D printing of firearms

Southeast Asian Leaders To Seek Clarity Of US Policies For The Region Form Pompeo

The world economy is accumulating environmental debt

US To Invest $113 Million In Asia To Counter Chinese Influence

US Intelligence Detects New Activity At Its Missile ICBM Factory: Reports